Showing results (171-180 of 281) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotypePaolo Salerno, Ginesa Garcia-Rostan, Sara Piccinin, et al.
Oncogene|October 25, 2003
Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid glandMaria Letizia Motti, Angelo Boccia, Barbara Belletti, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 12, 2019
RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteinsDaniela D'Angelo, Paula Mussnich, Romina Sepe, et al.
Molecular Carcinogenesis|May 4, 2017
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapyCristina Quintavalle, Katharina Burmeister, Salvatore Piscuoglio, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2017
HMGA2 cooperates with either p27<sup>kip1</sup> deficiency or Cdk4<sup>R24C</sup> mutation in pituitary tumorigenesisMonica Fedele, Orlando Paciello, Davide De Biase, et al.
Cancer Research|May 19, 2006
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancerFrancesco Paonessa, Daniela Foti, Vanessa Costa, et al.
Plos One|November 7, 2014
Structural model of the hUbA1-UbcH10 quaternary complex: in silico and experimental analysis of the protein-protein interactions between E1, E2 and ubiquitinStefania Correale, Ivan de Paola, Carmine Marco Morgillo, et al.
Carcinogenesis|June 17, 2003
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomasValeria Masciullo, Gustavo Baldassarre, Francesca Pentimalli, et al.
Nature Medicine|June 1, 2005
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and miceDaniela Foti, Eusebio Chiefari, Monica Fedele, et al.
The American Journal of Pathology|July 28, 2004
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinomaRosa Marina Melillo, Anna Maria Cirafici, Valentina De Falco, et al.
Pageof 29